FDA Approves New Molecularly Targeted Therapeutic for Non-Hodgkin Lymphoma

The flurry of treatments approved by the U.S. Food and Drug Administration (FDA) for treating hematological malignancies continued last week with the approval of the molecularly targeted therapeutic copanlisib (Aliqopa) for the treatment of certain adults with non-Hodgkin lymphoma.

Read More

AACR Runners for Research are Ready to Run, Raise Cancer Research Funds

A half marathon is a challenging goal for anyone. Several members of the American Association for Cancer Research (AACR) Runners for Research team endured an extra challenge: battling cancer as they trained for the AACR Rock ā€˜nā€™ Roll Philadelphia Half Marathon, set to take place Saturday, October 31.

Read More

Exploring Complement Biology to Improve Antibody-based Therapies for Non-Hodgkin Lymphoma

Among the many types of cancer acknowledged during the month of September is lymphoma, a cancer arising from a subset of white blood cells (lymphocytes) that compose an important part …

Read More